Pfizer’s Prevenar 13 Receives Expanded Age Range Approval in China
U.S.-based pharmaceutical giant Pfizer (NYSE: PFE) has reported receiving an additional indication approval from the...
BeiGene’s Tislelizumab-Chemo Combo Excels in RATIONALE 305 Trial for Gastric Cancer
BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235), a China-based biopharmaceutical company, has announced that the...
Zylox-Tonbridge Medical Teams Up with Hicicare Science for Guide Wire Product Sales in China
China-based nerve and peripheral vascular interventional device developer Zylox-Tonbridge Medical Technology (HKG: 2190) has announced...
Shanghai Ark Biopharmaceutical’s STAR Market IPO Filing Accepted, Aims to Raise $289.6 Million
Shanghai Ark Biopharmaceutical Co., Ltd’s Initial Public Offering (IPO) filing to the Shanghai Stock Exchange’s...
Hunan Warrant Pharmaceutical Receives NMPA Approval for Generic Brivudine
Hunan Warrant Pharmaceutical Co., Ltd (SHA: 688799), a China-based pharmaceutical company, has announced receiving marketing...
Junshi Biosciences’ Tuoyi Combo Shows Promise in Phase III Neotorch Study for NSCLC
China-based Junshi Biosciences (HKG: 1877, SHA: 688180) has published the results of the Phase III...
Jiangsu Aidea Pharmaceutical Secures Global Licensing Deal for Kainos Medicine’s HIV Drugs
Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488), a China-based pharmaceutical company, has entered into a...
Acotec Scientific’s Vericor-14 Microcatheter Receives NMPA Approval for Vascular Surgeries
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National...
Janssen’s Spravato Approved by NMPA for Adult Depression and Suicidal Ideation Treatment
Janssen’s Spravato (esketamine) has been granted approval by the National Medical Products Administration (NMPA) in...
Jiangxi Jemincare Group Secures Clinical Trial Approvals for Four Innovative Drugs
Jiangxi Jemincare Group, a China-based pharmaceutical company, has announced receiving clinical trial approvals for four...
CSPC Pharmaceutical Group Gets NMPA Approval for SYS6010 ADC Clinical Trial
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that it has received clinical trial...
Legend Biotech’s Carvykti Data Boosts Stock Price by 19.64% on Positive Phase III Results
Shares of Legend Biotech (NASDAQ: LEGN) jumped an impressive 19.64% in a single day, attributed...
Acotec Scientific Holdings Receives NMPA Approval for Paclitaxel-Coated Balloon Dilation Catheter
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National...
CARSgen Therapeutics’ CT041 Receives NMPA Approval for Post-Operative Pancreatic Cancer Therapy
China-based chimeric antigen receptor (CAR)-T cell specialist, CARSgen Therapeutics Holdings Ltd (HKG: 2171), has announced...
Zelgen Biopharmaceuticals’ ZG2001 Receives NMPA Approval for Clinical Trials
Suzhou Zelgen Biopharmaceuticals Co., Ltd (SHA: 688266) has announced that it has received clinical trial...
Beijing Aosaikang’s ASKG915 Receives NMPA Approval for Clinical Trials in Advanced Solid Tumors
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755) has announced receiving clinical trial approval for its...
InnoCare Pharma’s Orelabrutinib Gains NMPA Approval for Recurrent/Refractory MZL Treatment
China-based InnoCare Pharma (HKG: 9969, SHA: 688428) has announced receiving another indication approval from the...
Walvax Biotechnology’s RQ3013 mRNA Vaccine Shows Efficacy in Phase III Study
China’s Walvax Biotechnology Co., Ltd (SHE: 300142) has announced the efficacy interim results of a...
NMPA’s 2022 Drug Supervision Report: Clinical Trials and Market Filings on the Rise
The National Medical Products Administration (NMPA) has released its “Annual Drug Supervision and Administration Statistics...
Alcon Laboratories’ Innovative Intraocular Lens Approved by China’s NMPA
The National Medical Products Administration (NMPA) has granted import approval to US firm Alcon Laboratories,...